EPIDEMIOLOGY OF ADULT T-CELL LEUKEMIA/LYMPHOMA AND THE ACQUIRED IMMUNODEFICIENCY SYNDROME NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


EPIDEMIOLOGY OF ADULT T-CELL LEUKEMIA/LYMPHOMA AND THE ACQUIRED IMMUNODEFICIENCY SYNDROME

Retrovirus Biology and Human Disease. Gallo RC and Wong-Staal F, eds. New York, Marcel Dekker, p. 209-39, 1990.. Unique Identifier : AIDSLINE ICDB/91676225
Manns A; Blattner WA; Enviromental Epidemiology Branch, NCI, Bethesda, MD


Abstract: The discovery of the first human retrovirus, human T-lymphotropic virus (HTLV-I), was facilitated by advances in virologic and cell culture techniques. HTLV-I was linked with a specific clinical syndrome, adult T-cell leukemia/lymphoma (ATLL); this finding set the stage for discovery of HTLV-II and HIV-1. HTLV-II was isolated initially from a patient with hairy cell leukemia, but has not been consistently associated with any single disease. HIV-1 is associated with AIDS. The epidemiologies are reviewed, covering for ATLL, historic overview, geographic distribution, incidence/prevalence of HTLV-I and ATLL, modes of HTLV-I transmission, and other disease associations; and for AIDS, historic overview, demographics (United States, Europe and Latin America, and Africa), clinical spectrum (opportunistic infections, AIDS-related cancers [Kaposi's sarcoma and lymphomas], neurologic syndromes), and transmission of HIV infection (blood and blood products, sexual transmission, iv drug use, maternal-infant transmission, occupational exposure, and casual contact). Several features of ATLL and HTLV-I infection are apparent: (1) The disease and virus are endemic among the Japanese; blacks in southeastern United States, Caribbean, and Africa; and some individuals exposed via travel or born in an endemic area. (2) There is an age-dependent increase in prevalence of infection, with disease incidence peaking in the mid-40s. (3) There are no male:female differences in occurrence of ATLL. (4) There is a worldwide geographic distribution, with rural and coastal areas showing increased prevalence. (5) Transmission has been demonstrated to be sexual (specifically male-to-female, mother-to-child), through cellular blood products, and by needle sticks. (6) There is generally a long incubation period between infection and disease onset. (7) There is an apparently low rate of infectivity secondary to inefficient transmission, although the discovery of new disease associations may establish a more prominent role for this retroviral infection. Epidemiology has contributed considerably to establishing the retrovirus association with human disease. (157 Refs)
Keywords: Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY/TRANSMISSION Comparative Study Cross-Cultural Comparison Cross-Sectional Studies Human Incidence Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated/*EPIDEMIOLOGY/ TRANSMISSION Leukemia, T-Cell, HTLV-II-Associated/*EPIDEMIOLOGY/TRANSMISSION Risk Factors MONOGRAPH REVIEW

KWDacquiredimmunodeficiencysyndrome/KWDepidemiology/transmissioncomparativestudycross-culturalcomparisoncross-sectionalstudieshumanincidenceleukemia-lymphoma,t-cell,acute,htlv-i-associated/KWDepidemiology/transmissionleukemia,t-cell,htlv-ii-associated/KWDepidemiology/transmissionriskfactorsmonographreview
911130
M91B0828


Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .